Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

LU-302872, an orally active ETA/ETB antagonist for the treatment of BPH

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Ditropan XL effectively controls urge incontinence in phase III trial

June 5, 1998

Celsion to evaluate BPH system in phase I trial

June 3, 1998

RU-58642: potent new antiandrogen for androgen-dependent prostate disorders

June 2, 1998

PPD and Lilly join forces to develop genitourinary compounds

May 28, 1998

ETA antagonist has protective effects in hypertensive rat model of renal damage

May 27, 1998

Renal effects of BG-9719 demonstrated in CHF patients and healthy volunteers

May 22, 1998

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

Yamanouchi prepares novel antimuscarinic agents for renal, GI and respiratory disorders

May 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...